FDA Publishes COVID-19 Pandemic Recovery and Preparedness Plan Summary Report

January 14, 2021
BioPharm International Editors

A report on the FDA PREPP initiative’s work in 2020 aims to strengthen the Agency’s response to future public health emergencies.

FDA announced on Jan. 13, 2021 that it had published a report summarizing the work to date of the COVID-19 Pandemic Recovery and Preparedness Plan (PREPP) initiative, which was launched in August 2020 to strengthen the Agency’s response to the current pandemic and to future public health emergencies.

As part of the initiative, FDA asked an independent, non-government organization to review its pandemic response, record its accomplishments and activities, and pinpoint future opportunities for consideration, an FDA press release said. The organization interviewed FDA leaders, organized listening sessions with external stakeholder groups, and partnered with subject matter experts on the FDA staff to generate a summary report.

"We have a responsibility to learn from our actions to focus on what we can—and must—do better for the future,” FDA said in the press release. “Our experience so far has taught us that transparency and continuous improvement are the essential drivers of a successful response."

Source: FDA